Resources Contact Us Home
Solid oral dosage form containing an enhancer

Image Number 17 for United States Patent #8119159.

The invention relates to a pharmaceutical composition and oral dosage forms comprising a bisphosphonate in combination with an enhancer to promote absorption of the bisphosphonate at the GIT cell lining. The enhancer is a medium chain fatty acid or a medium chain fatty acid derivative having a carbon chain length of from 6 to 20 carbon atoms. Preferably, the solid oral dosage form is a controlled release dosage form such as a delayed release dosage form.

  Recently Added Patents
Satellite communication network
Self-service channel marketplace
Method and apparatus for a cryptographically assisted commercial network system designed to facilitate buyer-driven conditional purchase offers
Emergency call notification for network services
Self-assembled, micropatterned, and radio frequency (RF) shielded biocontainers and their uses for remote spatially controlled chemical delivery
Pointer display device, pointer display/detection method, pointer display/detection program and information apparatus
Apparatus and sensor for adjusting vertical sensor-alignment
  Randomly Featured Patents
System and method of controlling fluid to a fluid consuming battery
Process for preparing a filled steamed bagel product
Fuel cell engine having a propulsion motor operatively connected to drive a fluid supply device
Centrifugal casting of titanium alloys with improved surface quality, structural integrity and mechanical properties in isotropic graphite molds under vacuum
Pants, in particular riding jeans
Propagation and/or derivation of embryonic stem cells
Phase change inks containing compounds derived from isocyanate, unsaturated alcohol, and polyol
Space-efficient source routing
Electrochromic compound, electrochromic composition, and display device
Chemical analysis using dynamic viscometry